TRPV1 channels in arterial smooth muscle: a novel vasoconstrictor mechanism to promote maintained cerebral blood flow during acutedecreases in blood pressure

动脉平滑肌中的 TRPV1 通道:一种新型血管收缩机制,可在血压急性下降期间促进维持脑血流

基本信息

项目摘要

Precise control of arterial diameter throughout the body is essential to maintain perfusion pressure and blood flow to vital organs, such as the brain. Ca2+ influx through L-type voltage-dependent Ca2+ channels (VDCCs) has traditionally been viewed as the major Ca2+ entry pathway in arterial smooth muscle (ASM) that controls contraction and the regulation of arterial diameter. Here, we provide direct evidence for a second major Ca2+ entry pathway in some types of ASM—the transient receptor potential vanilloid 1 (TRPV1) channel, a “non-selective” Ca2+-permeable ion channel typically involved in nociception in sensory nerves. Using “optical patch-clamping” techniques, we provide the first measurements of Ca2+ influx through single TRPV1 channels (“sparklets”). Importantly, our preliminary data also demonstrate engagement of ASM TRPV1 channels by activation of 1-adrenergic receptors (1-ARs)—the major vasoconstrictor pathway of the sympathetic nervous system (SNS). The role of the SNS in maintaining cerebral blood flow (CBF) is particularly important during episodes of acute hypotension (e.g., hemorrhagic shock) and is achieved in part through 1- AR–mediated vasoconstriction in peripheral tissue. Our overarching hypothesis is that, in response to acute decreases in blood pressure, constriction of non-brain arteries possessing ASM TRPV1 channels tunes vascular resistance to redistribute blood to cerebral arteries, which we have found to lack TRPV1 channels. Within Aim 1, we explore the basis of TRPV1 activation by -ARs. The goal of this aim is to unravel the linkages between 1-ARs, ASM TRPV1 channels, Ca2+ signaling and arterial diameter. We believe the differential expression of TRPV1 and the activation of this channel by 1-AR ligands play important roles in the regulation ASM Ca2+ and arterial diameter by the SNS. Specifically, we test the hypothesis that SNS-evoked TRPV1 channel activation promotes increased global cytosolic Ca2+ and vasoconstriction via multiple pathways including: 1) direct Ca2+ entry through TRPV1 channels and, 2) TRPV1-mediated cation influx, membrane potential (VM) depolarization and enhanced VDCC activity. In Aim 2, we combine in vivo measurements of arterial diameter, ASM Ca2+ and CBF to elucidate the role of TRPV1 channels in promoting the maintenance of CBF during acute decreases in blood pressure that mimic hemorrhagic shock. In summary, this proposal is designed to provide unprecedented resolution of TRPV1 channel impact on arterial diameter and CBF. Identifying a key role for ASM TRPV1 in promoting CBF during acute decreases in blood pressure has the potential to provide a wealth of new information of great benefit to individual shock patients and our society at large.
精确控制全身动脉直径对于维持灌注压和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE C WELLMAN其他文献

GEORGE C WELLMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE C WELLMAN', 18)}}的其他基金

Supplemental Proposal for HL142888: Role of vascular and non-vascular TRPV1 channels in AD/ARD
HL142888 的补充提案:血管和非血管 TRPV1 通道在 AD/ARD 中的作用
  • 批准号:
    10289453
  • 财政年份:
    2019
  • 资助金额:
    $ 50.71万
  • 项目类别:
TRPV1 channels in arterial smooth muscle: a novel vasoconstrictor mechanism to promote maintained cerebral blood flow during acute decreases in blood pressure
动脉平滑肌中的 TRPV1 通道:一种新型血管收缩机制,可在血压急性下降期间促进维持脑血流
  • 批准号:
    10116452
  • 财政年份:
    2019
  • 资助金额:
    $ 50.71万
  • 项目类别:
TRPV1 channels in arterial smooth muscle: a novel vasoconstrictor mechanism to promote maintained cerebral blood flow during acute decreases in blood pressure
动脉平滑肌中的 TRPV1 通道:一种新型血管收缩机制,可在血压急性下降期间促进维持脑血流
  • 批准号:
    9903431
  • 财政年份:
    2019
  • 资助金额:
    $ 50.71万
  • 项目类别:
Impact of SAH on Parenchymal Arterioles and Neurovascular Coupling
SAH 对实质小动脉和神经血管耦合的影响
  • 批准号:
    7998908
  • 财政年份:
    2010
  • 资助金额:
    $ 50.71万
  • 项目类别:
Cerebral artery Ca2+ signaling & subarachnoid hemorrhage
脑动脉 Ca2 信号传导
  • 批准号:
    7838959
  • 财政年份:
    2009
  • 资助金额:
    $ 50.71万
  • 项目类别:
COBRE: UVM MED PROJ 5: CEREBRAL VASOSPASM MECHANISM IN SUBARACHNOID HEMORRHAGE
COBRE:UVM MED 项目 5:蛛网膜下腔出血中的脑血管痉挛机制
  • 批准号:
    7381253
  • 财政年份:
    2006
  • 资助金额:
    $ 50.71万
  • 项目类别:
COBRE: UVM MED PROJ 5: CEREBRAL VASOSPASM MECHANISM IN SUBARACHNOID HEMORRHAGE
COBRE:UVM MED 项目 5:蛛网膜下腔出血中的脑血管痉挛机制
  • 批准号:
    7170483
  • 财政年份:
    2005
  • 资助金额:
    $ 50.71万
  • 项目类别:
Cerebral artery Ca2+ signaling & subarachnoid hemorrhage
脑动脉 Ca2 信号传导
  • 批准号:
    7324766
  • 财政年份:
    2004
  • 资助金额:
    $ 50.71万
  • 项目类别:
Cerebral artery Ca2+ signaling & subarachnoid hemorrhage
脑动脉 Ca2 信号传导
  • 批准号:
    7146711
  • 财政年份:
    2004
  • 资助金额:
    $ 50.71万
  • 项目类别:
Cerebral artery Ca2+ signaling & subarachnoid hemorrhage
脑动脉 Ca2 信号传导
  • 批准号:
    6855926
  • 财政年份:
    2004
  • 资助金额:
    $ 50.71万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 50.71万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了